Apicortin was identified in silico, in 2009, as a characteristic protein of apicomplexans. It combines a partial p25alpha domain with a DCX (doublecortin) one. Based on its occurrence and one of its characteristic domains, it was termed apicortin. Apicortin, when identified, was shown to occur in apicomplexan parasites and in the placozoan animal, Trichoplax adhaerens. The apicomplexan genomes known then contained it without exception. This situation practically has not changed since then; this statement is valid for the newly sequenced genomes and transcriptomes of apicomplexans as well, almost without exception.
In 2009, apicortin was identified in silico as a characteristic protein of apicomplexans that also occurs in the placozoa, Trichoplax adhaerens. Since then, it has been found that apicortin also occurs in free-living cousins of apicomplexans (chromerids) and in flagellated fungi. It contains a partial p25-α domain and a doublecortin (DCX) domain, both of which have tubulin/microtubule binding properties. Apicortin has been studied experimentally in two very important apicomplexan pathogens, Toxoplasma gondii and Plasmodium falciparum. It is localized in the apical complex in both parasites. In T. gondii, apicortin plays a key role in shaping the structure of a special tubulin polymer, conoid. In both parasites, its absence or downregulation has been shown to impair pathogen–host interactions. Based on these facts, it has been suggested as a therapeutic target for treatment of malaria and toxoplasmosis.
2. Name
Apicortin was identified in silico, in 2009, as a characteristic protein of apicomplexans [1]. It combines a partial p25alpha domain with a DCX (doublecortin) one. Based on its occurrence and one of its characteristic domains, it was termed apicortin.
3. Apicortin
Apicortin, when identified, was shown to occur in apicomplexan parasites and in the placozoan animal,
Trichoplax adhaerens [
1]. The apicomplexan genomes known then contained it without exception. This situation practically has not changed since then; this statement is valid for the newly sequenced genomes and transcriptomes of apicomplexans as well. The only exception is the Apicomplexa with the smallest genome,
Babesia microti [
2].
Later it has been found that apicortin also occurs in chromerids, the recently discovered [
3,
4], free-living cousins of apicomplexans [
5]. This is not surprising, given the phylogenetic proximity and the structural similarity of these phyla. Unlike apicomplexan species, both
Chromera velia and
Vitrella brassicaformis have three apicortin paralogs. Apicortin has not been found in other related phyla of the Alveolata superphylum, although its remnant is present in the genome in the case of Perkinsozoa [
6]. However, the very recently published draft genome of
Perkinsus olseni contains hypothetical protein(s) possessing both p25alpha and DCX domains (KAF4710163, KAF4750811) [
7].
It has also been revealed that some primitive fungi also possess this protein; first it was shown in the cases of
Spizellomyces punctatus [
6] and
Rozella allomycis [
5]. Later, a systematic examination of fungal genomes showed that the flagellated fungi contain apicortin almost without exception; and it is present even in a non-flagellated but also deeper branching clade (Endogonomycetes) [
8].
Apicortin is one of the most abundant proteins of
T. adhaerens [
9]. This is the only animal that possesses apicortin [
10]. Animal draft genomes and transcriptomes contain sometimes nucleotide sequences, contigs and TSAs (transcriptome shot-gun assemblies), homologous to apicortin, but they have been shown to be contaminations from parasitizing apicomplexans, based on sequence similarities and GC ratios [
11,
12]. In the case of
T. adhaerens, this option was excluded by phylogenetic analysis [
8]. Several authors suggested that the presence of frequent contaminants could serve as a basis for the identification of hitherto unknown apicomplexans and, in general, parasites [
13,
14,
15]. The origin of a few plant and algal apicortin-like nucleotide sequences needs further investigations. My preliminary data suggest that contamination of apicomplexan origin can be ruled out but not that of fungal ones.
Strong correlation between the presence of the p25alpha domain and that of the eukaryotic flagellum was suggested before the identification of apicortin [
16]. With very few exceptions, each flagellated organism contains p25alpha domain-containing proteins; on the other side, in non-flagellated species, the p25alpha domain generally does not occur [
8,
10]. The protein that contains the p25alpha domain varies depending on the phylum; e.g., it is the so called “long-type” TPPP in animals (except
T. adhaerens) [
10,
17], a fungal-type TPPP and apicortin in flagellated fungi [
8], while the “short-type” TPPP and apicortin are found in apicomplexan species [
10]. With the exceptions of two non-flagellated fungi and some apicomplexans, apicortin can be found only in species which are flagellated, at least in some life stage.
4. Domains
Apicortin belongs to a eukaryotic protein superfamily, the TPPP-like proteins, characterized by the presence of the p25alpha domain (Pfam05517, IPR008907), and named after the first identified member, TPPP/p25, which exhibits microtubule stabilizing function [
10]. TPPP stands for tubulin polymerization promoting protein [
18,
19] and was first identified by Takahashi et al. as p25 protein [
20]. Full-length p25alpha domain consists of about 160 amino acids; however, that of the apicortin is incomplete, containing only the last 30–40 amino acids (a “partial p25alpha domain”). Importantly, the tubulin/microtubule binding amino acid sequence is located in this part of the domain [
21,
22,
23,
24]. This is the most conserved part of the domain, which contains a characteristic “Rossmann-like motif”, GXGXGXXGR [
10,
17].
However, apicortins possess another characteristic domain, the DCX one (Pfam03607, IPR003533) [
1]. The DCX (doublecortin) domain is named after the brain-specific X-linked gene doublecortin [
25]. It is a structural domain, which generally appears in duplicate as two tandemly repeated 80 amino acid regions (N- and C-terminal type DCX domains), but proteins containing only one DCX-repeat have also been identified [
26,
27]. This domain is also known to play a role in the stabilization of microtubules [
25,
26].
5. Conclusions
When apicortin was identified in silico, it was proposed that its function may be to stabilize specific cytoskeletal structures that are unique to apicomplexans [
1]. It has also been hypothesized that it might have a role in parasite–host interactions [
1,
5]. Recent experimental results support both assumptions [
28,
29,30,31]. Apicortin has been shown to be localized in the apical complex; more precisely, in
T. gondii, it is localized exclusively at the conoid, a tubulin-based structure that has an important role in host cell invasion [29]. Apicortin is essential for providing the correct structure and function of conoid. In
P. falciparum, which has no conoid, apicortin is localized at the apical end; it has been suggested that it is involved in the formation of the apical complex [30]. In both species, downregulation of apicortin leads to impaired host cell invasion [
28,31].
Apicomplexan species possess several hundred genes, which are specific for the phylum, and even more genes, which are absent in mammals/vertebrates but are present in these parasites. For example, apicomplexans have evolved hundreds of specialized invasion proteins, and contain lineage- and species-specific gene families, which are specialized for modulating host-specific adaptation [32]. Targeting parasite proteins that have crucial roles in these interactions is a key focus in the development of therapeutic agents against diseases caused by apicomplexan infection. Thus, apicortin, which seems to influence parasite–host interactions, is also a potential drug target. Since some mechanistic details of its function have been known, this protein has become more than a desirable target in drug development.
This entry is adapted from the peer-reviewed paper 10.3390/tropicalmed6030118